scholarly journals The phospholamban pentamer interacts with the sarcoplasmic reticulum calcium pump SERCA

2018 ◽  
Author(s):  
J. P. Glaves ◽  
J. O. Primeau ◽  
L. M. Espinoza-Fonseca ◽  
M. J. Lemieux ◽  
H. S. Young

ABSTRACTThe interaction of phospholamban with the sarcoplasmic reticulum calcium pump (SERCA) is a major regulatory axis in cardiac muscle contractility. The prevailing model involves reversible inhibition of SERCA by monomeric phospholamban and storage of phospholamban as an inactive pentamer. However, this paradigm has been challenged by studies demonstrating that phospholamban remains associated with SERCA and that the phospholamban pentamer is required for cardiac contractility. We have previously used two-dimensional crystallization and electron microscopy to study the interaction between SERCA and phospholamban. To further understand this interaction, we compared small helical crystals and large two-dimensional crystals of SERCA in the absence and presence of phospholamban. In both crystal forms, SERCA molecules are organized into identical anti-parallel dimer ribbons. The dimer ribbons pack together with distinct crystal contacts in the helical versus large two-dimensional crystals, which allow phospholamban differential access to potential sites of interaction with SERCA. Nonetheless, we show that a phospholamban oligomer interacts with SERCA in a similar manner in both crystal forms. In the two-dimensional crystals, a phospholamban pentamer interacts with transmembrane segments M3 of SERCA and participates in a crystal contact that bridges neighboring SERCA dimer ribbons. In the helical crystals, an oligomeric form of phospholamban also interacts with M3 of SERCA, though the phospholamban oligomer straddles a SERCA-SERCA crystal contact. We conclude that the pentameric form of phospholamban interacts with SERCA, and that it plays distinct structural and functional roles in SERCA regulation.

1998 ◽  
Vol 274 (1) ◽  
pp. H98-H105 ◽  
Author(s):  
Douglas L. Jones ◽  
Njanoor Narayanan

Presently, the only therapy for ventricular fibrillation is delivery of high-voltage shocks. Despite “successful defibrillation,” patients may have poor cardiac contractility, the mechanisms of which are unknown. Intracellular Ca2+ handling by the sarcoplasmic reticulum (SR) plays a major role in contractility. We tested the hypothesis that defibrillation shocks interfere with Ca2+ transport function of cardiac SR. Rats anesthetized with pentobarbital sodium had bilateral electrodes implanted subcutaneously for transthoracic shocks. A series of 10 shocks, 10 s apart, at 0–250 V was delivered from a trapezoidal defibrillator. The hearts were rapidly removed, SR-enriched membrane vesicles were isolated, and ATP-dependent Ca2+ uptake and Ca2+-stimulated ATP hydrolysis were determined. There was a marked, shock-related decline in Ca2+ uptake, whereas adenosinetriphosphatase activity remained unaltered. The polypeptide compositions were similar in control and shocked SR. In Langendorff hearts, shocks also decreased contractility and slowed relaxation. These data indicate that shocks with current densities similar to defibrillation depress Ca2+-pumping function of cardiac SR because of uncoupling of ATP hydrolysis and Ca2+ transport. Shock-induced impairment of Ca2+ pump function may underlie postshock myocardial dysfunction.


1985 ◽  
Vol 40 (7-8) ◽  
pp. 571-575 ◽  
Author(s):  
Wilhelm Hasselbach ◽  
Andrea Migala

Abstract The decline of the transport ratio of the sarcoplasmic calcium pump observed in a recent study (A. results from the retardation of calcium oxalate precipitation at low calcium/protein ratios. The prevailing high internal calcium level supports a rapid calcium backflux and a compensatory ATP hydrolysis during net calcium uptake which reduces the transport ratio. Yet, the determined calcium back­ flux does not fully account for the decline of the transport ratio. A supposed modulation of the stoichiometry of the pump by external calcium (0.1 μм) is at variance with results of previous studies showing a constant transport ratio of two in the same calcium concentration range.


2014 ◽  
Vol 70 (a1) ◽  
pp. C1066-C1066 ◽  
Author(s):  
John Glaves ◽  
Przemek Gorski ◽  
Catharine Trieber ◽  
David Stokes ◽  
Howard Young

Phospholamban and sarcolipin physically interact with the sarcoplasmic reticulum calcium pump (SERCA) and differentially regulate contractility in smooth, skeletal, and cardiac muscle. While mutagenesis and cross-linking studies have provided insight into the mechanism of interaction, we lack a molecular understanding of these regulatory complexes. We have compared two crystal forms of SERCA in the absence and presence of phospholamban by electron cryo-microscopy. Our previous studies with phospholamban utilized both small helical crystals [1] and large two-dimensional crystals [2], where the fundamental units of both crystal forms were found to be anti-parallel dimer ribbons of SERCA molecules. The SERCA dimer ribbons have been known for decades as a rigid assembly of calcium-free SERCA molecules induced by the addition of decavanadate. While the lattice formed by the SERCA dimer ribbons is different in the helical (p2) and two-dimensional crystals (p22121), we now show that a phospholamban oligomer interacts with SERCA in a similar manner in both crystal types. With this information, we next undertook a structural investigation of SERCA and sarcolipin in the large two-dimensional crystals. Both wild-type and a gain-of-function mutant (Asn4-to-Ala) mutant of sarcolipin were utilized. Projection maps were determined for SERCA in the presence of sarcolipin to a resolution of 8.5 Å and were most consistent with a pentameric state for sarcolipin. While both phospholamban and sarcolipin interacted with transmembrane segment M3 of SERCA, the interaction of the sarcolipin pentamer was mediated by an additional density consistent with a sarcolipin monomer.


Sign in / Sign up

Export Citation Format

Share Document